Studies analyzing paired ante mortem CSF and brain tissue samples have shown that 73% of A+T− individuals, as determined by CSF immunoassay, were pathologically confirmed to have AD, with both amyloid plaques and tau tangles present at autopsy.46 The gene discussed is MAPT; the disease is Alzheimer disease.